-
Orexo AB et al v. Actavis Elizabeth LLC et al DC
- 1:17-cv-00205
- D. Del.
- Judge: Colm F. Connolly
- Filed: 02/28/2017
- Closed: 12/12/2019
- Latest Docket Entry: 01/17/2020
- PACER
- Docket updated daily
2
Plaintiffs
4
Defendants
6
Accused
Products
1
Patent-in-Suit
1,018
Days in
Litigation
-
Orexo AB et al v. Actavis Elizabeth LLC et al DC
- 1:17-cv-00205
- D. Del.
- Judge: Colm F. Connolly
- Filed: 02/28/2017
- Closed: 12/12/2019
- Latest Docket Entry: 01/17/2020
- PACER
- Docket updated daily
Cause of Action
Willful Patent Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Actavis Elizabeth LLC
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
8mg/2mg dosage strengths8mg dosage strengthsbuprenorphine hydrochloride 2mgbuprenorphine hydrochloride and naloxone hydrochloride dihydrate 2mg/0.5mgGeneric Suboxone productsGeneric Subutex products | US 8,454,996 B2 |
2
|
No infringement
Entry 302Entry 275 |
Actavis Pharma Incorporated
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
8mg/2mg dosage strengths8mg dosage strengthsbuprenorphine hydrochloride 2mgbuprenorphine hydrochloride and naloxone hydrochloride dihydrate 2mg/0.5mgGeneric Suboxone productsGeneric Subutex products | US 8,454,996 B2 |
2
|
No infringement
Entry 302Entry 275 |
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
8mg/2mg dosage strengths8mg dosage strengthsbuprenorphine hydrochloride 2mgbuprenorphine hydrochloride and naloxone hydrochloride dihydrate 2mg/0.5mgGeneric Suboxone productsGeneric Subutex products | US 8,454,996 B2 |
2
|
No infringement
Entry 302
|
Teva Pharmaceuticals USA, Inc.
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
8mg/2mg dosage strengths8mg dosage strengthsbuprenorphine hydrochloride 2mgbuprenorphine hydrochloride and naloxone hydrochloride dihydrate 2mg/0.5mgGeneric Suboxone productsGeneric Subutex products | US 8,454,996 B2 |
2
|
No infringement
Entry 302
|